Limited Additive Diagnostic Impact of Isolated Gastrointestinal Involvement for the Triage of Children with Suspected COVID-19
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Caselli, D.; Aricò, M. 2019-nCoV: Polite with children! Pediatr. Rep. 2020, 12, 8495. [Google Scholar] [CrossRef] [Green Version]
- Lu, X.; Zhang, L.; Du, H.; Zhang, J.; Li, Y.Y.; Qu, J.; Zhang, W.; Wang, Y.; Bao, S.; Li, Y.; et al. SARS-CoV-2 Infection in Children. N. Engl. J. Med. 2020, 382, 1663–1665. [Google Scholar] [CrossRef] [Green Version]
- Loske, J.; Röhmel, J.; Lukassen, S.; Stricker, S.; Magalhães, V.G.; Liebig, J.; Chua, R.L.; Thürmann, L.; Messingschlager, M.; Seegebarth, A.; et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 2021. [Google Scholar] [CrossRef]
- Sheikh, A.; McMenamin, J.; Taylor, B.; Robertson, C.; Public Health Scotland and the EAVE II Collaborators. SARS-CoV-2 Delta VOC in Scotland: Demographics, risk of hospital admission, and vaccine effectiveness. Lancet 2021, 397, 2461–2462. [Google Scholar] [CrossRef]
- CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children—United States, February 12-April 2, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020, 69, 422. [Google Scholar] [CrossRef] [PubMed]
- Coronavirus Disease 2019 (COVID-19): Clinical Manifestations and Diagnosis in Children. Available online: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-clinical-manifestations-and-diagnosis-in-children (accessed on 6 August 2021).
- Caselli, D.; Chironna, M.; Loconsole, D.; Nigri, L.; Mazzotta, F.; Bonamonte, D.; Aricò, M. No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain. Br. J. Dermatol. 2020, 183, 784–785. [Google Scholar] [CrossRef]
- Hubiche, T.; Phan, A.; Leducq, S.; Rapp, J.; Fertitta, L.; Aubert, H.; Barbarot, S.; Chiaverini, C.; Giraudeau, B.; Lasek, A.; et al. Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clusters. Ann. Dermatol. Venereol. 2021, 148, 94–100. [Google Scholar] [CrossRef] [PubMed]
- Feldstein, L.R.; Tenforde, M.W.; Friedman, K.G.; Newhams, M.; Rose, E.B.; Dapul, H.; Soma, V.L.; Maddux, A.B.; Mourani, P.M.; Bowens, C.; et al. Characteristics and Outcomes of US Children and Adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) Compared with Severe Acute COVID-19. JAMA 2021, 325, 1074–1087. [Google Scholar] [CrossRef]
- Clark, J.A.; Pathan, N. Hide and seek in a pandemic: Review of SARS-CoV-2 infection and sequelae in children. Exp. Physiol. 2021, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Parasa, S.; Desai, M.; Thoguluva Chandrasekar, V.; Patel, H.K.; Kennedy, K.F.; Roesch, T.; Spadaccini, M.; Colombo, M.; Gabbiadini, R.; Artifon, E.L.A.; et al. Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients with Coronavirus Disease 2019: A Systematic Review and Meta-analysis. JAMA Netw. Open 2020, 3, e2011335. [Google Scholar] [CrossRef]
- Concas, G.; Barone, M.; Francavilla, R.; Cristofori, F.; Dargenio, V.N.; Giorgio, R.; Dargenio, C.; Fanos, V.; Marcialis, M.A. Twelve Months with COVID-19: What Gastroenterologists Need to Know. Dig. Dis. Sci. 2021, 1–21. [Google Scholar] [CrossRef]
- Jin, X.; Lian, J.-S.; Hu, J.-H.; Gao, J.; Zheng, L.; Zhang, Y.M.; Hao, S.R.; Jia, H.Y.; Cai, H.; Zhang, X.L.; et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020, 69, 1002–1009. [Google Scholar] [CrossRef] [Green Version]
- Guan, W.J.; Ni, Z.Y.; Hu, Y.; Liang, W.-H.; Ou, C.-Q.; He, J.-X.; Liu, L.; Shan, H.; Lei, C.-L.; Hui, D.S.C.; et al. China Medical Treatment Expert Group for COVID-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef] [PubMed]
- Xiong, X.L.; Wong, K.K.; Chi, S.Q.; Zhou, A.F.; Tang, J.Q.; Zhou, L.S.; Chung, P.H.; Chua, G.; Tung, K.; Wong, I.; et al. Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms. Gut 2021, 70, 436–438. [Google Scholar] [CrossRef] [PubMed]
- Xu, Y.; Li, X.; Zhu, B.; Liang, H.; Fang, C.; Gong, Y.; Guo, Q.; Sun, X.; Zhao, D.; Shen, J.; et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat. Med. 2020, 26, 502–505. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xia, W.; Shao, J.; Guo, Y.; Peng, X.; Li, Z.; Hu, D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr. Pulmonol. 2020, 55, 1169. [Google Scholar] [CrossRef] [Green Version]
- Dong, Y.; Mo, X.; Hu, Y.; Qi, X.; Jiang, F.; Jiang, Z.; Tong, S. Epidemiology of COVID-19 among children in China. Pediatrics 2020, 145, e20200702. [Google Scholar] [CrossRef] [Green Version]
- Zachariah, P.; Johnson, C.L.; Halabi, K.C.; Ahn, D.; Sen, A.I.; Fischer, A.; Banker, S.L.; Giordano, M.; Manice, C.S.; Diamond, R.; et al. Epidemiology, Clinical Features, and Disease Severity in Patients with Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York. JAMA Pediatr. 2020, 174, e202430. [Google Scholar] [CrossRef]
- Assa, A.; Benninga, M.A.; Borrelli, O.; Broekaert, I.; de Carpi, J.M.; Saccomani, M.D.; Dolinsek, J.; Mas, E.; Miele, E.; Thomson, M.; et al. Gastrointestinal Perspective of COVID-19 in Children—An Updated Review. J. Pediatr. Gastroenterol. Nutr. 2021, 73, 299–305. [Google Scholar] [CrossRef]
- Al-Beltagi, M.; Saeed, N.K.; Bediwy, A.S.; El-Sawaf, Y. Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications. World J. Gastroenterol. 2021, 27, 1716–1727. [Google Scholar] [CrossRef]
- Calitri, C.; Fumi, I.; Ignaccolo, M.G.; Banino, E.; Benetti, S.; Lupica, M.M.; Fantone, F.; Pace, M.; Garofalo, F. Gastrointestinal involvement in paediatric COVID-19—From pathogenesis to clinical management: A comprehensive review. World J. Gastroenterol. 2021, 27, 3303–3316. [Google Scholar] [CrossRef] [PubMed]
- Akobeng, A.K.; Grafton-Clarke, C.; Abdelgadir, I.; Twum-Barimah, E.; Gordon, M. Gastrointestinal manifestations of COVID-19 in children: A systematic review and meta-analysis. Frontline Gastroenterol. 2020, 12, 332–337. [Google Scholar] [CrossRef]
- Loconsole, D.; Caselli, D.; Centrone, F.; Morcavallo, C.; Campanella, S.; Aricò, M.; Chironna, M. SARS-CoV-2 Infection in Children in Southern Italy: A Descriptive Case Series. Int. J. Environ. Res. Public Health 2020, 17, 6080. [Google Scholar] [CrossRef] [PubMed]
- Available online: https://regione.puglia.it/web/speciale-coronavirus/-/bollettino-epidemiologico-del-24-agosto-2021 (accessed on 25 August 2021).
- Caselli, D.; Loconsole, D.; Dario, R.; Chironna, M.; Aricò, M. Effectiveness of Preventive Measures in Keeping Low Prevalence of SARS-CoV-2 Infection in Health Care Workers in a Referral Children’s Hospital in Southern Italy. Pediatr. Rep. 2021, 13, 118–124. [Google Scholar] [CrossRef] [PubMed]
- Pérez-Gaxiola, G.; Flores-Rocha, R.; Valadez-Vidarte, J.C.; Hernández-Alcaraz, M.; Herrera-Mendoza, G.; Real-Lugo, M.Á.D. Clinical and epidemiological characteristics of children with SARS-CoV-2 infection: A case series in Sinaloa. Bol. Med. Hosp. Infant. Mex. 2021, 78, 18–23. [Google Scholar] [CrossRef]
- Alsohime, F.; Temsah, M.H.; Al-Nemri, A.M.; Somily, A.M.; Al-Subaie, S. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. J. Infect. Public Health 2020, 13, 1791–1796. [Google Scholar] [CrossRef]
- Struyf, T.; Deeks, J.J.; Dinnes, J.; Takwoingi, Y.; Davenport, C.; Leeflang, M.M.; Spijker, R.; Hooft, L.; Emperador, D.; Domen, J.; et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst. Rev. 2021, 2, CD013665. [Google Scholar] [CrossRef]
- Yang, T.Y.; Li, Y.C.; Wang, S.C.; Dai, Q.Q.; Jiang, X.S.; Zuo, S.; Jia, L.; Zheng, J.B.; Wang, H.L. Clinical characteristics of patients with COVID-19 presenting with gastrointestinal symptoms as initial symptoms: Retrospective case series. World J. Clin. Cases. 2020, 8, 2950–2958. [Google Scholar] [CrossRef]
- Stacevičienė, I.; Burokienė, S.; Steponavičienė, A.; Vaičiūnienė, D.; Jankauskienė, A. A cross-sectional study of screening for coronavirus disease 2019 (COVID-19) at the pediatric emergency department in Vilnius during the first wave of the pandemic. Eur. J. Pediatr. 2021, 180, 2137–2145. [Google Scholar] [CrossRef]
- Mantovani, A.; Netea, M.G. Trained Innate Immunity, Epigenetics, and COVID-19. N. Engl. J. Med. 2020, 383, 1078–1080. [Google Scholar] [CrossRef]
- Bartsch, Y.C.; Wang, C.; Zohar, T.; Fischinger, S.; Atyeo, C.; Burke, J.S.; Kang, J.; Edlow, A.G.; Fasano, A.; Baden, L.R.; et al. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat. Med. 2021, 27, 454–462. [Google Scholar] [CrossRef] [PubMed]
- Long, Q.X.; Tang, X.J.; Shi, Q.L.; Li, Q.; Deng, H.J.; Yuan, J.; Hu, J.L.; Xu, W.; Zhang, Y.; Lv, F.J.; et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 2020, 26, 1200–1204. [Google Scholar] [CrossRef] [PubMed]
- Ibarrondo, F.J.; Fulcher, J.A.; Goodman-Meza, D.; Elliott, J.; Hofmann, C.; Hausner, M.A.; Ferbas, K.G.; Tobin, N.H.; Aldrovandi, G.M.; Yang, O.O. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild COVID-19. N. Engl. J. Med. 2020, 383, 1085–1087. [Google Scholar] [CrossRef] [PubMed]
- Weisberg, S.P.; Connors, T.J.; Zhu, Y.; Baldwin, M.R.; Lin, W.H.; Wontakal, S.; Szabo, P.A.; Wells, S.B.; Dogra, P.; Gray, J.; et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 2021, 22, 25–31. [Google Scholar] [CrossRef] [PubMed]
- Denina, M.; Pruccoli, G.; Scolfaro, C.; Mignone, F.; Zoppo, M.; Giraudo, I.; Silvestro, E.; Bertolotti, L.; Rosati, S.; Ramenghi, U.; et al. Sequelae of COVID-19 in Hospitalized Children: A 4-Months Follow-Up. Pediatr. Infect. Dis. J. 2020, 39, e458–e459. [Google Scholar] [CrossRef]
- Waterfield, T.; Watson, C.; Moore, R.; Ferris, K.; Tonry, C.; Watt, A.; McGinn, C.; Foster, S.; Evans, J.; Lyttle, M.D.; et al. Seroprevalence of SARS-CoV-2 antibodies in children: A prospective multicentre cohort study. Arch Dis. Child. 2020, 106, 680–686. [Google Scholar] [CrossRef]
- Duysburgh, E.; Mortgat, L.; Barbezange, C.; Dierick, K.; Fischer, N.; Heyndrickx, L.; Hutse, V.; Thomas, I.; Van Gucht, S.; Vuylsteke, B.; et al. Persistence of IgG response to SARS-CoV-2. Lancet Infect. Dis. 2021, 21, 163–164. [Google Scholar] [CrossRef]
- Prado-Vivar, B.; Becerra-Wong, M.; Guadalupe, J.J.; Márquez, S.; Gutierrez, B.; Rojas-Silva, P.; Grunauer, M.; Trueba, G.; Barragán, V.; Cárdenas, P. A case of SARS-CoV-2 reinfection in Ecuador. Lancet Infect. Dis. 2021, 21, e142. [Google Scholar] [CrossRef]
- Ju, B.; Zhang, Q.; Ge, J.; Wang, R.; Sun, J.; Ge, X.; Yu, J.; Shan, S.; Zhou, B.; Song, S.; et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 2020, 584, 115–119. [Google Scholar] [CrossRef]
- Tarke, A.; Sidney, J.; Methot, N.; Yu, E.D.; Zhang, Y.; Dan, J.M.; Goodwin, B.; Rubiro, P.; Sutherland, A.; Wang, E.; et al. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals. Cell Rep. Med. 2021, 2, 100355. [Google Scholar] [CrossRef]
- Kinoshita, H.; Durkee-Shock, J.; Jensen-Wachspress, M.; Kankate, V.V.; Lang, H.; Lazarski, C.A.; Keswani, A.; Webber, K.C.; Montgomery-Recht, K.; Walkiewicz, M.; et al. Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency. J. Clin. Immunol. 2021, 41, 1146–1153. [Google Scholar] [CrossRef] [PubMed]
- Caselli, D.; Aricò, M. SARS-CoV-2 Vaccination for Children-An Open Issue. Pediatr. Rep. 2021, 13, 95–97. [Google Scholar] [CrossRef] [PubMed]
- Walter, E.B.; Talaat, K.R.; Sabharwal, C.; Gurtman, A.; Lockhart, S.; Paulsen, G.C.; Barnett, E.D.; Muñoz, F.M.; Maldonado, Y.; Pahud, B.A.; et al. Evaluation of the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age. N. Engl. J. Med. 2021. [Google Scholar] [CrossRef] [PubMed]
Total Patients | 137 |
Gender | |
Female | 64 |
Male | 73 |
Age | |
Range (years) | 0–17.9 |
Median | 2.6 |
Patients with at least one COVID-19 related sign or symptom (n = 122) | |
Type | N. (%) |
Fever | 98 (81%) |
Respiratory symptoms (cough, breathing difficulties) | 79 (58%) |
Fever and respiratory symptoms | 64 (47%) |
Diarrhea | 35 (25%) |
Isolated diarrhea | 5 (3.6%) |
Vomiting | 16 (13%) |
Vomiting and diarrhea | 5 (4%) |
Abdominal pain | 1 (0.7%) |
Fever, respiratory symptoms, and diarrhea | 16 (12%) |
Patients with Non-COVID-19 related signs or symptoms (n = 15) | |
Neuro-psychological disorders | 4 (3%) |
Trauma | 3 (2%) |
Bone pain | 3 (2%) |
Cancer | 2 (1%) |
Pancreatitis | 1 (0.7%) |
Ovary mass | 1 (0.7%) |
Hematuria | 1 (0.7%) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Caselli, D.; Cafagno, C.; Loconsole, D.; Giannini, A.; Tansella, F.; Saracino, A.; Chironna, M.; Aricò, M. Limited Additive Diagnostic Impact of Isolated Gastrointestinal Involvement for the Triage of Children with Suspected COVID-19. Children 2022, 9, 41. https://doi.org/10.3390/children9010041
Caselli D, Cafagno C, Loconsole D, Giannini A, Tansella F, Saracino A, Chironna M, Aricò M. Limited Additive Diagnostic Impact of Isolated Gastrointestinal Involvement for the Triage of Children with Suspected COVID-19. Children. 2022; 9(1):41. https://doi.org/10.3390/children9010041
Chicago/Turabian StyleCaselli, Désirée, Claudio Cafagno, Daniela Loconsole, Annamaria Giannini, Francesco Tansella, Annalisa Saracino, Maria Chironna, and Maurizio Aricò. 2022. "Limited Additive Diagnostic Impact of Isolated Gastrointestinal Involvement for the Triage of Children with Suspected COVID-19" Children 9, no. 1: 41. https://doi.org/10.3390/children9010041